This is an aptamer development services to screening aptamers binds to the SETD3 with an affinity of 1nM~1μM.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Target Category | Protein |
| Target | SETD3 |
| Alternative Names | SET Domain Containing 3, Actin Histidine Methyltransferase; Actin-Histidine N-Methyltransferase; SET Domain-Containing Protein 3; SET Domain Containing 3; C14orf154; HSETD3; Histone-Lysine N-Methyltransferase Setd3; Chromosome 14 Open Reading Frame 154; EC 2.1.1.85; FLJ23027; SETD3 |
| Gene ID | |
| UniProt ID | Q86TU7 |
| Target Overview | SETD3 (SET Domain Containing 3, Actin Histidine Methyltransferase) is a Protein Coding gene. Diseases associated with SETD3 include Meier-Gorlin Syndrome 1. Among its related pathways are PKMTs methylate histone lysines and Chromatin organization. Gene Ontology (GO) annotations related to this gene include transcription coactivator activity and histone methyltransferase activity (H3-K4 specific). An important paralog of this gene is SETD6. |
| Chemical Modification | N/A |
| Type | DNA |
| Length | 20-80 nt |
| Affinity (Kd) | 1nM~1μM |
| Binding Conditions/Buffer | PBS; buffer system with Serum; other |